Ariboflavinosis

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Ariboflavinosis
Error creating thumbnail: File missing
riboflavin
ICD-10 E53
ICD-9 266.0

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for Ariboflavinosis

Articles

Most recent articles on Ariboflavinosis

Most cited articles on Ariboflavinosis

Review articles on Ariboflavinosis

Articles on Ariboflavinosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ariboflavinosis

Images of Ariboflavinosis

Photos of Ariboflavinosis

Podcasts & MP3s on Ariboflavinosis

Videos on Ariboflavinosis

Evidence Based Medicine

Cochrane Collaboration on Ariboflavinosis

Bandolier on Ariboflavinosis

TRIP on Ariboflavinosis

Clinical Trials

Ongoing Trials on Ariboflavinosis at Clinical Trials.gov

Trial results on Ariboflavinosis

Clinical Trials on Ariboflavinosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ariboflavinosis

NICE Guidance on Ariboflavinosis

NHS PRODIGY Guidance

FDA on Ariboflavinosis

CDC on Ariboflavinosis

Books

Books on Ariboflavinosis

News

Ariboflavinosis in the news

Be alerted to news on Ariboflavinosis

News trends on Ariboflavinosis

Commentary

Blogs on Ariboflavinosis

Definitions

Definitions of Ariboflavinosis

Patient Resources / Community

Patient resources on Ariboflavinosis

Discussion groups on Ariboflavinosis

Patient Handouts on Ariboflavinosis

Directions to Hospitals Treating Ariboflavinosis

Risk calculators and risk factors for Ariboflavinosis

Healthcare Provider Resources

Symptoms of Ariboflavinosis

Causes & Risk Factors for Ariboflavinosis

Diagnostic studies for Ariboflavinosis

Treatment of Ariboflavinosis

Continuing Medical Education (CME)

CME Programs on Ariboflavinosis

International

Ariboflavinosis en Espanol

Ariboflavinosis en Francais

Business

Ariboflavinosis in the Marketplace

Patents on Ariboflavinosis

Experimental / Informatics

List of terms related to Ariboflavinosis

Overview

Ariboflavinosis is the medical condition caused by deficiency of riboflavin (vitamin B2). Ariboflavinosis is most often seen in association with protein-energy malnutrition, and also in cases of alcoholism.

It was originally known as pellagra sin pellagra, as it exhibits certain similarities to the niacin deficiency pellagra. The most common cause of riboflavin deficiency is an inadequate diet, thus it occurs most frequently in populations consuming limited quantities of riboflavin-containing foods such as meats, eggs, milk, cheese, yogurt, leafy green vegetables and whole grains. Riboflavin deficiency can also occur in those with impaired liver function, which prevents proper utilization of the vitamin. Borderline riboflavin deficiency as a consequence of certain anti-retroviral medications has also been known to cause acute lactic acidosis.

The signs and symptoms of riboflavin deficiency typically include sore throat with redness and swelling of the mouth and throat mucosa, cheilosis and angular stomatitis (cracking of the lips and corners of the mouth), glossitis (magenta tongue with atrophy), seborrheic dermatitis or pseudo-syphilis (moist, scaly skin particularly affecting the scrotum or labia majora and the nasolabial folds), and a decreased red blood cell count with normal cell size and hemoglobin content (normochromic normocytic anemia).

Riboflavin deficiency is usually found together with other nutrient deficiencies, particularly of the other water-soluble vitamins. Phototherapy to treat jaundice in infants can cause increased degradation of riboflavin, leading to deficiency if not monitored closely. Persons with chronic alcoholism can have impaired absorption of riboflavin and other vitamins such as thiamine (see Wernicke's encephalopathy).

Studies of the Turkoman people of Iran, who have a significantly increased incidence of esophageal cancer, have shown some relationship between chronic riboflavin deficiency and the onset of esophageal malignancies. One study of pregnant women has found that riboflavin-deficient women were 4.7 times more likely to develop preeclampsia, though the mechanism for this is not known.

The US Recommended Daily Allowance (RDA) for riboflavin ranges from 1.1 to 1.3 milligrams per day for healthy adults to as high as 1.6 mg/day for pregnant or nursing women.

External link

Reference

  • Wacker J, Frühauf J, Schulz M, Chiwora FM, Volz J, Becker K (2000). "Riboflavin deficiency and preeclampsia". Obstetrics and gynecology. 96 (1): 38–44. PMID 10862839.


Template:Nutritional pathology


Template:WikiDoc Sources